Screener
Arrowhead Pharmaceuticals, Inc. ARWR Q4 2026 Annual earnings
Reported November 12, 2026 · After market close
Revenue$37.8MMiss by $23.4M
EPS-$3.04Miss by $1.52
Revenue estimate$61.2M
EPS estimate-$1.52
Next report
Feb 4, 2027 (in 3 months)Revenue estimate$40.8M
EPS estimate-$1.46
Valuation & ratios
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Arrowhead Pharmaceuticals, Inc. report Q4 2026 earnings?
- Arrowhead Pharmaceuticals, Inc. (ARWR) reported Q4 2026 earnings on November 12, 2026 after market close.
- What were Arrowhead Pharmaceuticals, Inc.'s Q4 2026 revenue and EPS?
- Arrowhead Pharmaceuticals, Inc. reported revenue of $37.8M and eps of $-3.04 for Q4 2026.
- Did Arrowhead Pharmaceuticals, Inc. beat estimates in Q4 2026?
- Revenue missed the consensus estimate of $61.2M by $23.4M. EPS missed the consensus estimate of $-1.52 by $1.52.
- How did Arrowhead Pharmaceuticals, Inc.'s Q4 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 85.3% from $256.5M a year earlier and eps declined 1588.9% from $-0.18.
- Where can I find Arrowhead Pharmaceuticals, Inc.'s Q4 2026 SEC filings?
- You can read the 8-K earnings release (0000879407-26-000077) and the 10-K periodic report (0000879407-26-000078) directly on SEC EDGAR. The filing index links above go to sec.gov.
